Menu

Image of the Day: Call the Coral Doctor

Scientists surveyed coral colonies in Hawaii for disease after a mystery pathogen caused tissue from the common rice coral (Montipora capitata) to degenerate.   

Jun 22, 2017
The Scientist Staff

Disease ecologist and postdoctoral fellow Jamie Caldwell of Stanford University and the University of Hawaii (red fins), and research assistant Sean Dimoff (blue fins) survey coral in Kaneohe Bay, Oahu, Hawaii, in February 2015.

DAVID SLATER

   According to disease ecologist Jamie Caldwell of Stanford University and the University of Hawaii, scientists don’t know what made common rice coral (Montipora capitata) in Hawaii sick in 2015. “[O]ur study indicated that it was an infectious disease that targets larger than average coral colonies,” Caldwell tells The Scientist in an email.

But as part of a research team recently funded by NASA to create tools that predict coral diseases, Caldwell is working to prevent such outbreaks. “[U]nderwater visual surveys rely on disease lesions we can see with the naked eye, at which point the coral is already very affected by the disease," she says in a news release. Using new tools, scientist wish to better predict and manage risk factors before disease ensues.

July 2019

On Target

Researchers strive to make individualized medicine a reality

Marketplace

Sponsored Product Updates

IDT and Washington University join forces to increase access to the latest NGS technologies
IDT and Washington University join forces to increase access to the latest NGS technologies
As part of its commitment to advocate for the genomics age, Integrated DNA Technologies (IDT) aims to lower the barriers to access the latest NGS technologies.
Bio-Rad Launches Bio-Plex Pro Human Immunotherapy Panel 20-plex Multiplex Assay, a targeted tool for researching signaling networks in Immunotherapy Research
Bio-Rad Launches Bio-Plex Pro Human Immunotherapy Panel 20-plex Multiplex Assay, a targeted tool for researching signaling networks in Immunotherapy Research
Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb) July 15, 2019 announced the launch of its Bio-Plex Pro Human Immunotherapy Panel 20-plex, a multiplex immunoassay that offers a targeted approach for Immunotherapy Research.
DeNovoMAX - NRGene's new genomics tool to meet a major agbio need:
DeNovoMAX - NRGene's new genomics tool to meet a major agbio need:
NRGene has launched a new product that aims to empower breeding and maximize agricultural yield as part of the Denovo assembly product suite offered by the company.
Overcoming the Efficiency Challenge in Clinical NGS
Overcoming the Efficiency Challenge in Clinical NGS
Download this white paper to see how an ECS lab serving a network of more than 10,000 healthcare providers integrated QIAGEN Clinical Insight (QCI) Interpret to significantly reduce manual variant curation efforts and increase workflow efficiency by 80%!